Literature DB >> 23723063

Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.

Hannah J Whittington1, Idris Harding, Clemency I M Stephenson, Robert Bell, Derek J Hausenloy, Mihaela M Mocanu, Derek M Yellon.   

Abstract

AIMS: Old age and diabetes are risk factors that often coexist increasing the vulnerability of the heart to the lethal effects of ischaemia-reperfusion injury (IRI). However, to our knowledge, no investigations have examined IRI and cardioprotective signalling in animal models bearing these co-morbidities concomitantly. The ability of the heart to recover following IRI is greatly dependent on its innate cardioprotective potential, in which a central role is played by Akt. We aimed to investigate in an aging diabetic rat model, the susceptibility of the heart to IRI, the achievability of ischaemic preconditioning (IPC) against this lethal event, and the changes in Akt signalling, as the main prosurvival intracellular pathway. METHODS AND
RESULTS: Our data showed that the isolated hearts of aged, diabetic Goto-Kakizaki rats were more susceptible to sub-lethal injury and not amenable to cardioprotection via IPC, compared with younger diabetic rat hearts. Western blot analysis of the heart tissue suggested a chronic up-regulation of Akt phosphorylation, and reduced expression of the mitochondrial regulator PGC-1α and of the anti-oxidant enzyme catalase, potentially due to the Akt up-regulation. Moreover, no further activation of Akt could be achieved following IPC.
CONCLUSION: An increased susceptibility to IRI in the aged, diabetic heart could be a consequence of impaired Akt signalling due to chronic Akt phosphorylation. Additional Akt phosphorylation required for IPC protection may therefore not be possible in the aged, diabetic rat heart and may explain why this cardioprotective manoeuvre cannot be achieved in these hearts.

Entities:  

Keywords:  Age; Akt; Diabetes; Ischaemic preconditioning; Myocardial infarct

Mesh:

Substances:

Year:  2013        PMID: 23723063      PMCID: PMC3746954          DOI: 10.1093/cvr/cvt140

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  50 in total

1.  Mutual dependence of Foxo3a and PGC-1alpha in the induction of oxidative stress genes.

Authors:  Yolanda Olmos; Inmaculada Valle; Sara Borniquel; Alberto Tierrez; Estrella Soria; Santiago Lamas; Maria Monsalve
Journal:  J Biol Chem       Date:  2009-03-26       Impact factor: 5.157

2.  Prognostic value of elevated biomarkers in diabetic and non-diabetic patients admitted for acute coronary syndromes.

Authors:  R Fazel; J Fang; E Kline-Rogers; D E Smith; K A Eagle; D Mukherjee
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

3.  Hypertensive hypertrophied myocardium is vulnerable to infarction and refractory to erythropoietin-induced protection.

Authors:  Toshiyuki Yano; Takayuki Miki; Masaya Tanno; Atsushi Kuno; Takahito Itoh; Akifumi Takada; Tatsuya Sato; Hidemichi Kouzu; Kazuaki Shimamoto; Tetsuji Miura
Journal:  Hypertension       Date:  2010-11-08       Impact factor: 10.190

4.  Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury.

Authors:  D Schulman; D S Latchman; D M Yellon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-10       Impact factor: 4.733

5.  Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes.

Authors:  S B Kristiansen; B Løfgren; N B Støttrup; D Khatir; J E Nielsen-Kudsk; T T Nielsen; H E Bøtker; A Flyvbjerg
Journal:  Diabetologia       Date:  2004-10-07       Impact factor: 10.122

6.  Effect of acute hyperglycaemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischaemic late preconditioning in the rabbit heart in vivo.

Authors:  Dirk Ebel; Jost Müllenheim; Jan Frässdorf; Andre Heinen; Ragnar Huhn; Thomas Bohlen; Jan Ferrari; Hendrik Südkamp; Benedikt Preckel; Wolfgang Schlack; Volker Thämer
Journal:  Pflugers Arch       Date:  2003-03-26       Impact factor: 3.657

Review 7.  Animal models in type 2 diabetes research: an overview.

Authors:  K Srinivasan; P Ramarao
Journal:  Indian J Med Res       Date:  2007-03       Impact factor: 2.375

8.  Impaired Akt phosphorylation in insulin-resistant human muscle is accompanied by selective and heterogeneous downstream defects.

Authors:  K T Tonks; Y Ng; S Miller; A C F Coster; D Samocha-Bonet; T J Iseli; A Xu; E Patrick; J Y H Yang; J R Junutula; Z Modrusan; G Kolumam; J Stöckli; D J Chisholm; D E James; J R Greenfield
Journal:  Diabetologia       Date:  2013-01-24       Impact factor: 10.122

9.  Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1.

Authors:  R Marfella; M D'Amico; C Di Filippo; E Piegari; F Nappo; K Esposito; L Berrino; F Rossi; D Giugliano
Journal:  Diabetologia       Date:  2002-06-26       Impact factor: 10.122

10.  Defining and characterizing the progression of type 2 diabetes.

Authors:  Vivian A Fonseca
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more
  34 in total

Review 1.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

Review 2.  Effect of hyperglycaemia and diabetes on acute myocardial ischaemia-reperfusion injury and cardioprotection by ischaemic conditioning protocols.

Authors:  Claudia Penna; Ioanna Andreadou; Manuela Aragno; Christophe Beauloye; Luc Bertrand; Antigone Lazou; Ines Falcão-Pires; Robert Bell; Coert J Zuurbier; Pasquale Pagliaro; Derek J Hausenloy
Journal:  Br J Pharmacol       Date:  2020-03-09       Impact factor: 8.739

Review 3.  Ischaemic conditioning: pitfalls on the path to clinical translation.

Authors:  Karin Przyklenk
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

4.  Plasma exosomes characterization reveals a perioperative protein signature in older patients undergoing different types of on-pump cardiac surgery.

Authors:  Alessandro Carrozzo; Valentina Casieri; Dario Di Silvestre; Francesca Brambilla; Emanuele De Nitto; Nicola Sardaro; Gaia Papini; Simona Storti; Giuseppina Settanni; Marco Solinas; Pierluigi Mauri; Domenico Paparella; Vincenzo Lionetti
Journal:  Geroscience       Date:  2020-07-20       Impact factor: 7.713

5.  Remote ischemic preconditioning fails to reduce infarct size in the Zucker fatty rat model of type-2 diabetes: role of defective humoral communication.

Authors:  Joseph Wider; Vishnu V R Undyala; Peter Whittaker; James Woods; Xuequn Chen; Karin Przyklenk
Journal:  Basic Res Cardiol       Date:  2018-03-09       Impact factor: 17.165

Review 6.  Ischemic conditioning: the challenge of protecting the diabetic heart.

Authors:  Joseph Wider; Karin Przyklenk
Journal:  Cardiovasc Diagn Ther       Date:  2014-10

7.  Role of the PI3K/AKT signalling pathway in apoptotic cell death in the cerebral cortex of streptozotocin-induced diabetic rats.

Authors:  Yan Meng; Weiwei Wang; Jinsong Kang; Xinxue Wang; Liankun Sun
Journal:  Exp Ther Med       Date:  2017-03-23       Impact factor: 2.447

8.  Metformin in Diabetic Patients with Heart Failure: Safe and Effective?

Authors:  Ijeoma Ananaba Ekeruo; Amirreza Solhpour; Heinrich Taegtmeyer
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-12-01

9.  Ischemic postconditioning confers cardioprotection and prevents reduction of Trx-1 in young mice, but not in middle-aged and old mice.

Authors:  Virginia Perez; Verónica D Annunzio; Tamara Mazo; Timoteo Marchini; Lourdes Caceres; Pablo Evelson; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2016-03-01       Impact factor: 3.396

Review 10.  Ageing, sex, and cardioprotection.

Authors:  Marisol Ruiz-Meana; Kerstin Boengler; David Garcia-Dorado; Derek J Hausenloy; Tuuli Kaambre; Georgios Kararigas; Cinzia Perrino; Rainer Schulz; Kirsti Ytrehus
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.